Pharma CEO Series: An Evening with Robert Chess, Chairman of Nektar Therapeutics

Wednesday, March 7 • 6:30 PM • San Francisco
 

Rob Chess is Chairman of Nektar Therapeutics, (NASDAQ:NKTR), a health care biotechnology company developing new treatments for cancer, autoimmune diseases, and pain.


   Click here for details and to buy tickets   

   
_________________________________________________________________________
 




Haven't yet set up your HarvardKey account? Claim your HarvardKey at key.harvard.edu.

Faculty, Staff, Parents, and Non-Alumni Members and Guests – Please login here

____________________________________________________________________________

Stay Connected with the Harvard Club of San Francisco!


Sign up for our e-newsletter

Join the HCSF Facebook Group
Join the HCSF Young Alums Facebook Group
Join our LinkedIn group

Upcoming Events